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S104 Poster Presentation – Tuberculosis
Short course) program in Chennai city catering to more than 5
million population were studied to determine the patient delay
and the treatment seeking pattern of TB patients and the various
reasons attributed to it.
Methods: A cross sectional survey among 300 TB patients was
done using a pre-coded semi-quantitative questionnaire between
March and June 2007.
Results: Of 300 patients, 30.6% patients were diagnosed at their
ﬁrst point of contact with health facility. About 75.6% of patients
were diagnosed by second visit, 89.3% patients were diagnosed
by third visit and the remaining were diagnosed up to sixth visit.
There were 326 shifts of facilities among 69.4% patients not
diagnosed at ﬁrst point of contact.
Majority (51.2%) of shifts were attributed to patients not getting
better, while 42.6% attributed the shifting to being referred by
the consulting doctor. Other reasons included inability to afford
treatment (3.7%) recommendations by friends to seek care in a
particular facility, convenience, luck (2.5%). The mean days of
patient delay in seeking care was 18.3 (median 7).
Conclusions: Patient delay in seeking care in this study was
less when compared to other studies. Around two thirds of te
patients had been diagnosed by their second point of contact
with health facility which could be due to improved networking
of private health providers for referral into government system
and increased awareness of patients about DOTS facilities.
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In spite of broad utilization of pyrazinamide in tuberculosis and
AIDS treatment schemes its effects on reproductive function and
posterity remains insufﬁciently investigated and present results
are discrepant.
Effects of oral administration of pyrazinamide (500 mg/kg b.w.,
1000 mg/kg b.w.) on liver and reproductive toxicity indices were
studied in experiments on Wistar male and pregnant (1-19 days
of pregnancy) female rats.
Pyrazinamide caused dose dependent increasing of p-nitrophenol
hydroxylase activity (as cytochrome P450 2E1 marker) in liver of
males and pregnant females with the simultaneously activation of
Kupffer cells. At the same time NADPH-dependent lipid peroxida-
tion was increased by 53% in pregnant females’ liver microsomal
fraction and by 86% in males’ liver microsomes. In males pyraz-
inamide administration produced dose-dependent spermatozoid
number decreasing in epididimys. Decrease of spermatogonia
number and compensatory increase of 12th meiosis stages with
synchronous dystrophic changes of spermatogenic epithelia also
were registered at these conditions. Administration of pyrazi-
namide in pregnant females caused dose independent increase
of preimplantational and postimplantational embryos death. In
conclusion, this study provides evidences in support of the role
cytochrome P450 2E1 in the reproductive toxicity of xenobiotics,
which metabolised with the participation of this isoform.
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Background: The study was done to evaluate the dispensing
practices of anti-tuberculosis (TB) drugs by private pharmacies
and the feasibility of involving them in DOTS (Directly Observed
Treatment, Short course) program between April 2006 and August
2007 in Chennai city, India.
Methods: Among the 1925 pharmacies registered under Pharmacy
Association of Chennai under 10 Corporation zones, 402 pharma-
cies selected by stratiﬁed sampling technique from 4 zones were
interviewed with a pilot tested semi-structured questionnaire.
They were then sensitized on their role in the DOTS program
through workshops and one to one visits and were invited to
contribute to the program by educating patients and by referring
patients to appropriate treatment facilities.
Results: Among the 402 pharmacies, 89% of pharmacists were
aware of symptoms of TB and 48% were aware that TB was
diagnosed by sputum examination. While 90% of the interviewed
pharmacies were dispensing anti-TB drugs, only 27% of them
knew about DOTS program. However, almost all of them were
willing to participate in the DOTS program. About 101 TB suspects
were referred from 64 pharmacies in the 1-year period following
their sensitization.
Conclusion: Private pharmacies play a key role in inﬂuencing
patients’ treatment choices and in guiding them to appropriate
health care facilities. This role becomes more important in tuber-
culosis control considering numerous treatment options available
to patients. This study has demonstrated that pharmacists can
be effectively used for case referral and the National TB control
program needs to respond to them positively.
